INDIGO Home University of Illinois at Urbana-Champaign logo uic building uic pavilion uic student center

Perinatal Depressive Symptoms in HIV-Infected Versus HIV-Uninfected Women: A Prospective Study from Preconception to Postpartum

Show full item record

Bookmark or cite this item: http://hdl.handle.net/10027/8399

Files in this item

File Description Format
PDF jwh.2010.2485.pdf (233KB) (no description provided) PDF
Title: Perinatal Depressive Symptoms in HIV-Infected Versus HIV-Uninfected Women: A Prospective Study from Preconception to Postpartum
Author(s): Rubin, Leah H.; Cook, Judith A.; Grey, Dennis D.; Weber, Kathleen; Wells, Christina; Golub, Elizabeth T.; Wright, Rodney L.; Schwartz, Rebecca M.; Goparaju, Lakshmi; Cohan, Deborah; Wilson, Melissa L.; Maki, Pauline M.
Subject(s): HIV perinatal
Abstract: Objective: Depression is common among HIV-infected women, predicts treatment nonadherence, and consequently may impact vertical transmission of HIV. We report findings from a study evaluating preconception, pregnancy, and postpartum depressive symptoms in HIV-infected vs. at-risk, HIV-uninfected women. Methods: We examined the prevalence and predictors of elevated perinatal (i.e., pregnancy and/or postpartum) depressive symptoms using a Center for Epidemiological Studies-Depression (CES-D) scale score of ≥16 in 139 HIV-infected and 105 HIV-uninfected women (62% African American) from the Women's Interagency HIV Study (WIHS). Results: The prevalence of elevated perinatal depressive symptoms did not differ by HIV serostatus (HIV-infected 44%, HIV-uninfected 50%, p=0.44). Among HIV-infected women, the strongest predictor of elevated symptoms was preconception depression (odds ratio [OR] 5.71, 95% confidence interval [CI] 2.67-12.19, p<0.001); crack, cocaine, and/or heroin use during preconception was marginally significant (OR 3.10, 95% CI 0.96-10.01, p=0.06). In the overall sample, additional significant predictors of perinatal depression included having multiple sex partners preconception (OR 2.20, 95% CI 1.12-4.32, p=0.02), use of preconception mental health services (OR 2.51, 95% CI 1.03-6.13, p=0.04), and not graduating from high school (OR 1.92, 95% CI 1.06-3.46, p=0.03). Conclusions: Elevated perinatal depressive symptoms are common among HIV-infected and at-risk HIV-uninfected women. Depressive symptoms before pregnancy were the strongest predictor of perinatal symptoms. Findings underscore the importance of early and ongoing assessment and treatment to ensure low vertical transmission rates and improving postpregnancy outcomes for mothers and children.
Issue Date: 2011-09-09
Publisher: Mary Ann Liebert
Citation Info: Rubin, L. H., Cook, J. A., Grey, D. D., Weber, K., Wells, C., Golub, E. T., Wright, R. L., Schwartz, R. M., Goparaju, L., Cohan, D., Wilson, M. L., & Maki, P. M. 2011. Perinatal Depressive Symptoms in HIV-Infected Versus HIV-Uninfected Women: A Prospective Study from Preconception to Postpartum. Journal of Women's Health. DOI: 10.1089/jwh.2010.2485.
Type: Article
Description: This is a copy of an article published in the Journal of Women's Health © 2011 [copyright Mary Ann Liebert, Inc.]; Journal of Women's Health is available online at: http://www.liebertonline.com. DOI: 10.1089/jwh.2010.2485.
URI: http://hdl.handle.net/10027/8399
ISSN: 1540-9996
Sponsor: Data in this article were collected by the Women's Interagency HIV Study (WIHS) Collaborative Study Group with centers (Principal Investigators) at New York City/Bronx Consortium (Kathryn Anastos); Brooklyn, NY (Howard Minkoff); Washington, DC, Metropolitan Consortium (Mary Young); The Connie Wofsy Study Consortium of Northern California (Ruth Greenblatt); Los Angeles County/Southern California Consortium (Alexandra Levine); Chicago Consortium (Mardge Cohen); Data Coordinating Center (Stephen Gange). The WIHS is funded by the National Institute of Allergy and Infectious Diseases (UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, and UO1-AI-42590) and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (UO1-HD-32632). The study is cofunded by the National Cancer Institute, the National Institute on Drug Abuse, and the National Institute on Deafness and Other Communication Disorders. Funding is also provided by the National Center for Research Resources (UCSF-CTSI grant UL1 RR024131). This publication was also made possible by Grant Number K12HD055892 from the National Institute of Child Health and Human Development (NICHD) and the National Institutes of Health Office of Research on Women's Health (ORWH).
Date Available in INDIGO: 2012-06-27
 

This item appears in the following Collection(s)

Show full item record

Statistics

Country Code Views
United States of America 74
China 15
United Kingdom 12
Canada 4
Netherlands 3

Browse

My Account

Information

Access Key